Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jeffrey Martin

Jeffrey Martin Danta, Clearwater, FL US

Patent application numberDescriptionPublished
20130186293PRINTED GELATIN CAPSULE AND METHOD OF MANUFACTURE - A paintball or other gelatin capsule has a printed image applied to its shell before encapsulation using a gelatin ribbon printing machine. The printing machine includes a motor driven cylindrical casting drum, a cylindrical print roll having a pattern formed on and around its outer periphery, said print roll being positioned relative to said casting drum so that said gelatin ribbon is sandwiched in between and in contact with both said casting drum and said print roll and so that the print roll is rotary driven by said casting drum solely through frictional contact with the gelatin ribbon. A rotary ink roller is in contact with the print roll to drives the ink roller solely through frictional contact between said print roll the inking roller. A doctor blade is configured to scrape excess ink from said inking roller. A method of printing on a gelatin capsule is also provided.07-25-2013

Jeffrey Martin Davis, Liss Forest GB

Patent application numberDescriptionPublished
20150076012CAP WITH ADDITIVE CHAMBER AND ASSOCIATED PACKAGING UNIT - The present invention comprises a cap (03-19-2015

Jeffrey Martin Gimble, Chapel Hill, NC US

Patent application numberDescriptionPublished
20090162934MULTIPLE MESODERMAL LINEAGE DIFFERENTIATION POTENTIALS FOR ADIPOSE TISSUE-DERIVED STROMAL CELLS AND USES THEREOF - The invention relates to methods and compositions for the differentiation of stromal cells from adipose tissue into hematopoietic supporting stromal cells and myocytes of both the skeletal and smooth muscle type. The cells produced by the methods are useful in providing a source of fully differentiated and functional cells for research, transplantation and development of tissue engineering products for the treatment of human diseases and traumatic tissue injury repair.06-25-2009

Jeffrey Martin Gimble, Baton Rouge, LA US

Patent application numberDescriptionPublished
20110250590MULTIPLE MESODERMAL LINEAGE DIFFERENTIATION POTENTIALS FOR ADIPOSE TISSUE-DERIVED STROMAL CELLS AND USES THEREOF - The invention relates to methods and compositions for the differentiation of stromal cells from adipose tissue into hematopoietic supporting stromal cells and myocytes of both the skeletal and smooth muscle type. The cells produced by the methods are useful in providing a source of fully differentiated and functional cells for research, transplantation and development of tissue engineering products for the treatment of human diseases and traumatic tissue injury repair.10-13-2011
20130017604USE OF ADIPOSE TISSUE-DERIVED STROMAL CELLS FOR CHONDROCYTE DIFFERENTIATION AND CARTILAGE REPAIR - Methods and compositions for directing adipose-derived stromal cells cultivated in vitro to differentiate into cells of the chondrocyte lineage are disclosed. The invention further provides a variety of chondroinductive agents which can be used singly or in combination with other nutrient components to induce chondrogenesis in adipose-derived stromal cells either in cultivating monolayers or in a biocompatible lattice or matrix in a three-dimensional configuration. Use of the differentiated chondrocytes for the therapeutic treatment of a number of human conditions and diseases including repair of cartilage in vivo is disclosed.01-17-2013
20130288262Multiple Mesodermal Lineage Differentiation Potentials for Adipose Tissue-Derived Stromal Cells and Uses Thereof - The invention relates to methods and compositions for the differentiation of stromal cells from adipose tissue into hematopoietic supporting stromal cells and myocytes of both the skeletal and smooth muscle type. The cells produced by the methods are useful in providing a source of fully differentiated and functional cells for research, transplantation and development of tissue engineering products for the treatment of human diseases and traumatic tissue injury repair.10-31-2013
20150099300USE OF ADIPOSE TISSUE-DERIVED STROMAL CELLS FOR CHONDROCYTE DIFFERENTIATION AND CARTILAGE REPAIR - Methods and compositions for directing adipose-derived stromal cells cultivated in vitro to differentiate into cells of the chondrocyte lineage are disclosed. The invention further provides a variety of chondroinductive agents which can be used singly or in combination with other nutrient components to induce chondrogenesis in adipose-derived stromal cells either in cultivating monolayers or in a biocompatible lattice or matrix in a three-dimensional configuration. Use of the differentiated chondrocytes for the therapeutic treatment of a number of human conditions and diseases including repair of cartilage in vivo is disclosed.04-09-2015

Patent applications by Jeffrey Martin Gimble, Baton Rouge, LA US

Jeffrey Martin Horejsi, Montgomery, MN US

Patent application numberDescriptionPublished
20090179337Quick-attach steam dispersion tubes and method of attachment - A steam dispersion system is disclosed. The steam dispersion system includes a header and a mounting plate spaced from the header. A steam dispersion tube including a first end and a second end and an interior cavity defined between the first end and the second end is mounted between the mounting plate and the header. The steam dispersion tube defines a longitudinal axis. A biasing structure is mounted between the mounting plate and the header, wherein the biasing structure applies a biasing force on the steam dispersion tube along a direction parallel to the longitudinal axis of the steam dispersion tube when mounted between the header and the mounting plate.07-16-2009
20130334715QUICK-ATTACH STEAM DISPERSION TUBES AND METHOD OF ATTACHMENT - A steam dispersion system is disclosed. The steam dispersion system includes a header and a mounting plate spaced from the header. A steam dispersion tube including a first end and a second end and an interior cavity defined between the first end and the second end is mounted between the mounting plate and the header. The steam dispersion tube defines a longitudinal axis. A biasing structure is mounted between the mounting plate and the header, wherein the biasing structure applies a biasing force on the steam dispersion tube along a direction parallel to the longitudinal axis of the steam dispersion tube when mounted between the header and the mounting plate.12-19-2013

Jeffrey Martin Sernett, Kelley, IA US

Patent application numberDescriptionPublished
20150272057PLANTS AND SEEDS OF CORN VARIETY CV969360 - According to the invention, there is provided seed and plants of the corn variety designated CV969360. The invention thus relates to the plants, seeds and tissue cultures of the variety CV969360, and to methods for producing a corn plant produced by crossing a corn plant of variety CV969360 with itself or with another corn plant, such as a plant of another variety. The invention further relates to corn seeds and plants produced by crossing plants of variety CV969360 with plants of another variety, such as another inbred line. The invention further relates to the inbred and hybrid genetic complements of plants of variety CV969360.10-01-2015

Jeffrey Martin Thompson, Tir Y Berth GB

Patent application numberDescriptionPublished
20130072567TREATMENT OF FAECAL INCONTINENCE AND OTHER CONDITIONS WITH 1R, 2S-METHOXAMINE - 1R,2S-Methoxamine may be used topically for effective treatment of faecal incontinence at low doses without local or systemic side effects, for example, without affecting blood pressure. 1R,2S-Methoxamine may be used to treat other disturbances and disorders of the gastro-intestinal, as a pressor agent, as a nasal decongestant and in ophthalmology, at low does and without significant side effects.03-21-2013

Jeffrey Martin Thompson, Mid Glamorgan GB

Patent application numberDescriptionPublished
20100022657Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine - 1R,2S-Methoxamine may be used topically for effective treatment of faecal incontinence at low doses without local or systemic side effects, for example, without affecting blood pressure. 1R,2S-Methoxamine may be used to treat other disturbances and disorders of the gastrointestinal, as a pressor agent, as a nasal decongestant and in ophthalmology, at low does and without significant side effects.01-28-2010
Website © 2015 Advameg, Inc.